Back
DexCom, Inc. (DXCM)
Health CareDXCM · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$92.34
+2.35%Weekly undervalued picks
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$2.06
ROE
35.6%
Gross margin
61.5%
Debt/Equity
0.47x
Revenue growth
15.0%
DexCom, Inc. — company intelligence
Earnings surprises
Q2 2026$0.70 vs $0.62 est+12.4%
Q1 2026$0.56 vs $0.48 est+17.0%
Q4 2025$0.56 vs $0.48 est+17.0%
Q3 2025$0.61 vs $0.58 est+5.3%
Analyst consensus · 36 analysts
31 Buy5 Hold0 Sell
Updated Aug 11, 2026
Insider activity · 90 days
10 buys10 sellsnet -22,104 shares
FOLETTA MARK GSell 2,000 · Aug 3, 2026
FOLETTA MARK GSell 2,000 · Jul 31, 2026
SAYER KEVIN RSell 26,756 · Jul 20, 2026
Recent SEC filings
4 — Insider transaction reportAug 13, 2026
4 — Insider transaction reportAug 13, 2026
4 — Insider transaction reportAug 4, 2026
Latest news
Dexcom (NASDAQ:DXCM) Combines Strong Growth With a Bullish Technical Setup — ChartMill · 5d ago
DexCom (DXCM) Rebounds On Growth Hopes, Does It Look Fully Valued? — Yahoo · 1w ago
1 Growth Stock to Stash and 2 We Brush Off — Yahoo · 1w ago
Is Wall Street Bullish or Bearish on DexCom Stock? — Yahoo · 1w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.